文献速递颈动脉与弓上血管

经颈动脉血运重建术治疗颈动脉狭窄的新模式

Transcarotid Artery Revascularization as a New Modality of Treatment for Carotid Stenosis.
PubMed 文献 · Ann Vasc Surg · 2019-11-06

本文系统综述了2009年1月至2019年8月间关于经颈动脉血运重建术(TCAR)的临床研究,共纳入8项研究(5项单臂研究、3项对比研究)。结果显示TCAR技术成功率高(90.6%-100%),围术期卒中、心肌梗死和死亡率低,且与经股动脉颈动脉支架置入相比院内卒中/短暂性脑缺血发作率更低,与颈动脉内膜切除术相比颅神经损伤风险更低。

要点

  • TCAR技术成功率高,围术期卒中、心梗和死亡风险低。
  • 与经股动脉支架相比,TCAR院内卒中/TIA率更低。
  • 与内膜切除术相比,TCAR颅神经损伤风险更低。

核心结论

  • TCAR联合血流逆转是颈动脉闭塞性疾病有前景的治疗选择。

研究设计与样本

  • 系统文献综述,检索PubMed和EMBASE数据库2009年1月至2019年8月关于TCAR联合血流逆转的临床研究。
  • 共纳入8项研究,包括5项单臂研究和3项对比研究。

主要发现

  • TCAR技术成功率为90.6%至100%。
  • 围术期卒中率为0至4%,心肌梗死率为0至0.7%,死亡率为0至2.7%。
  • 与经股动脉颈动脉支架置入相比,TCAR与更低的院内卒中/短暂性脑缺血发作率显著相关。
  • 与颈动脉内膜切除术相比,TCAR围术期卒中/心肌梗死/死亡无显著差异,但颅神经损伤风险显著更低。

临床怎么用

  • TCAR可作为颈动脉狭窄的治疗选择,尤其适用于关注颅神经损伤风险的患者。

局限性

  • 纳入研究数量有限(8项),且多为单臂研究。
  • 需要正在进行的临床试验提供更好的结局报告和与颈动脉内膜切除术的进一步比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid artery stenosis is a significant cause of ischemic stroke, and studies have shown that transfemoral carotid artery stenting is associated with a higher perioperative stroke risk than open endarterectomy. Transcarotid artery revascularization (TCAR) is a novel technique in carotid stenting via direct transcervical carotid access without the risk of arch manipulation, offers a smaller wound compared with endarterectomy, and employs flow reversal to decrease the risk of antegrade embolic stroke. Contemporary evidence on the safety and efficacy of TCAR is reviewed. METHODS: A systematic literature review on TCAR from January 2009 to August 2019 was performed in PubMed and EMBASE databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement. Clinical studies on TCAR with flow reversal with clinical outcomes of stroke, myocardial infarction (MI), and death were included. RESULTS: Initial search of the literature yielded 161 articles, of which 8 studies were included comprising of 5 single-arm studies and 3 comparative studies. Studies demonstrated high technical success rates of TCAR from 90.6% to 100%, with low perioperative stroke, MI, and mortality rates of 0 to 4%, 0 to 0.7% and 0 to 2.7%, respectively. TCAR was significantly associated with a lower in-hospital stroke/transient ischemic attack rate when compared to transfemoral carotid stenting. There was no significant difference in perioperative stroke/MI/death when compared to endarterectomy although TCAR had a significantly lower risk of cranial nerve injury. CONCLUSIONS: TCAR with flow reversal is a promising treatment option for carotid occlusive disease. Clinical trials are currently underway to provide a better report on outcomes of TCAR and for further comparison between TCAR and carotid endarterectomy.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Luk Y, Chan YC, Cheng SW, et al. Transcarotid Artery Revascularization as a New Modality of Treatment for Carotid Stenosis. Ann Vasc Surg. 2019. PMID: 31705988. doi:10.1016/j.avsg.2019.11.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。